Sichenzia Ross Ference Carmel LLP Represents Qualigen Therapeutics, Inc. in $3.47 Million Public Offering
Press Release – New York, NY – September 6, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented Qualigen Therapeutics, Inc. in the pricing of its $3.47 million public offering.
Univest Securities, LLC acted as the exclusive placement agent for the offering, led by Bradley Richmond.
The SRFC team was led by partner Ross Carmel and associates Bonnie Bai and Jesse Blue.
